The treatment of neuropathic pain: Antidepressants and opioids

Clinical Journal of Pain

Volumn 16, Issue 2 SUPPL., 2000, Pages

  Watson, C Peter N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

Neuropathic pain; Pain treatment

Indexed keywords

AMITRIPTYLINE; ANILERIDINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CLOMIPRAMINE; CODEINE; DESIPRAMINE; DIAZEPAM; DOCUSATE SODIUM; FENTANYL; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; HYDROMORPHONE; IMIPRAMINE; LEVORPHANOL; MAPROTILINE; MORPHINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; OPIATE; OXYCODONE; PERPHENAZINE; PHENOTHIAZINE; PLACEBO; THIORIDAZINE; TRAZODONE; UNINDEXED DRUG; ZIMELDINE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG INDICATION; HUMAN; NEUROPATHY; PAIN; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0002814591     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200006001-00009     Document Type: Conference Paper

References (57)

1. Mitchell SW. Injuries of nerves and their consequences. Philadelphia: JB Lippincott;1872:270.
2. Merskey H, Bogduk N. Classification of chronic pain, 2nd ed. Seattle: IASP Press, 1994.
3. Kingery W. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-39.
4. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The Consort Statement. JAMA 1996;276:637-63.
5. Kurtzke JF. Neuroepidemiology. Ann Neurol 1984;16:265-77.
6. Watson CPN. Postherpetic neuralgia: a review. Arch Neurol 1986; 43:836-40.
7. Watson CPN. Postherpetic neuralgia: an end stage, intractable disorder and the importance of prevention. J Infect Dis 1998;178 (Suppl 1):S91-4.
8. Woodforde JM, Dwyer B, McEwen BW, et al. The treatment of postherpetic neuralgia. Med J Aust 1965;2:869-72.
9. Taub A. Relief of postherpetic neuralgia with psychotropic drugs. J Neurosurg 1973;39:235-9.
10. Taub A, Collins WF. Observations on the treatment of denervation dysesthesia with psychotropic drugs. Adv Neurol 1974;4:309-15.
11. Watson CPN, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-3.
12. Max MB, Schafer SC, Culnane M, et al. Amitriptyline but not lorazepam relieves postherpetic neuralgia. Neurology 1988;38: 1427-32.
13. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in postherpetic neuralgia. Pain 1985;23:387-94.
14. Watson CPN, Evans RJ, Watt VR, Birkett N. Postherpetic neuralgia: 208 cases. Pain 1988;35:289-98.
15. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47:305-12.
16. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized double-blind crossover trial. Pain 1992;48:298-36.
17. Watson CPN, Vernich L, Chipman M, Reed K. Amitriptyline versus nortriptyline in postherpetic neuralgia. Neurology 1998;51: 1166-71.
18. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984;19:1379-82.
19. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986;25:171-86.
20. Urban BJ, France RD, Steinberger DL, et al. Long-term use of narcotic-antidepressant medication in the management of phantom limb pain. Pain 1986;24:191-7.
21. Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain 1992;49:87-91.
22. Mercadante S, Maddaloni S, Roccella S, Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain 1992;50:151-5.
23. Zenz M, Strumpf M, Tryba M. Long-term opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:89-97.
24. Portenoy RK. Opioid therapy for chronic nonmalignant pain. Pain Res Manage 1996;1:17-28.
25. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for postherpetic neuralgia. Ann Neurol 1994;35 (Suppl):S54-56.
26. Rowbotham MC, Reisner-Keller IA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991;41:1024-8.
27. Dellemijn PL, Vanneste JA. Randomized double-blind active placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997;349:753-8.
28. Watson CPN, Babul N. Oxycodone relieves neuropathic pain: a randomized trial on postherpetic neuralgia. Neurology 1998;50: 1837-41.
29. Davis JL, Lewis SB, Erich JE, et al. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA 1977;238: 2291-2.
30. Gomez-Perez FJ, Rull JA, Dies H, et al. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind study. Pain 1985;23:395-400.
31. Turkington RW. Depression masquerading as diabetic neuropathy. JAMA 1980;243:1147-50.
32. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984;251:1727-30.
33. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37:589-96.
34. Morello CM, Lechband SG, Stoner CP, et al. Randomized double blind trial of gabapentin with amitriptyline in diabetic peripheral neuropathy pain. Arch Intern Med 1999;59:1931-7.
35. Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991;45:3-9.
36. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
37. Vrethem M, Boivie J, Arnqvist H, et al. A comparison of amitriptyline and maprotiline in the treatment of painful diabetic neuropathy in diabetics and nondiabetics. Clin J Pain 1997;13:313-23.
38. Sindrup SH, Gram LF, Skjokl T, et al. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990;47:509-15.
39. Sindrup SH, Ejlertsen B, Froland A, et al. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomie nerve function. Eur J Clin Pharmacol 1989;37:151-3.
40. Sindrup SH, Tuxen C, Gram LF, et al. The effect of manserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol 1992; 43:251-5.
41. Sindrup SH, Grodum B, Gram LF, Beck-Nielsen H. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study. Ther Drug Monit 1991;13:408-14.
42. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44.
43. Sindrup SH, Gram LV, Skjold T, et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990;30: 683-91.
44. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-52.
45. Harati Y, Gooch C, Swenson MD, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842-6.
46. Sindrup SH, Andersen G, Madsen O, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized double-blind controlled trial. Pain 1999;83:85-90.
47. Leijon O, Boivie J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
48. Davidoff G, Guarrinci M, Roth E, et al. Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study. Pain 1987; 29:151-61.
49. Leijon G, Boivie J. Pharmacological treatment of central pain. In: Casey KL, ed. Pain and central nervous system disease. New York: Raven Press;1991:257-66.
50. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-27.
51. Backonja M, Beydoun A, Edwards KK, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-7.
52. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
53. Goldman B, Gayle G, Gilchrist G, et al. Use of opioids for the treatment of chronic pain of nonmalignant origin. Pain Res Manage 1997;2:231-5.
54. Hagen N, Flynne P, Hays H, et al. Guidelines for managing chronic non-malignant pain: opioids and other agents. Can Fam Physician 1995;41:49-53.
55. Moulin D. Opioid analgesics for chronic nonmalignant pain. Can J Contin Med Educ 1996;8:137-44.
56. Portenoy R. Opioid therapy for chronic nonmalignant pain. Pain Res Manage 1996;1:17-28.
57. Canadian Pain Society. Use of opioid analgesics for the treatment of chronic non-malignant pain. A consensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 1998;3: 197-208.